CliffBio
small molecule

HYDROCORTISONE

HYDROCORTISONE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCORTISONE
Active ingredientHYDROCORTISONE
Strength1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
Marketing statusDISCN

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.